Evidence map›Paper›PMID 33846213›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2021

Dopamine Prevents Ultraviolet B-induced Development and Progression of Premalignant Cutaneous Lesions through its D

Kai Lu, Madhavi Bhat, Sara Peters, Rita Mitra, Xiaokui Mo, Tatiana M Oberyszyn, Partha Sarathi Dasgupta, Sujit Basu

Open access · bronzeAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Dopamine D2 Receptor Agonists as Modulators of VEGF-A-Driven Angiogenesis: Mechanisms, Clinical Evidence, and Translational Opportunities.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  2. Ghrelin induced by ultraviolet B exposure promotes the restoration of diabetic cutaneous wound healing.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kai LuDepartment of Pathology, Ohio State University, Columbus, Ohio.
Madhavi BhatDepartment of Pathology, Ohio State University, Columbus, Ohio.
Sara PetersDepartment of Pathology, Ohio State University, Columbus, Ohio.ORCID 0000-0001-7781-4799
Rita MitraDepartment of Pathology, KPC Medical College, Kolkata, India.
Xiaokui MoDepartment of SBS-Biomedical Informatics, Ohio State University, Columbus, Ohio.
Tatiana M OberyszynDepartment of Pathology, Ohio State University, Columbus, Ohio.
Partha Sarathi DasguptaChittaranjan National Cancer Institute, Kolkata, India.
Sujit BasuDepartment of Pathology, Ohio State University, Columbus, Ohio. sujit.basu@osumc.edu.
The Ohio State University · USChittaranjan National Cancer Institute · INKPC Medical College and Hospital · IN

Funding

Dopamine as a therapeutic agent in stomach cancerR01CA169158 · NCI · OHIO STATE UNIVERSITY · PI BASU, SUJIT · 2013 to 2017
$1.6M
Role of chebulinic acid in angiogenesisR01HL131405 · NHLBI · OHIO STATE UNIVERSITY · PI BASU, SUJIT · 2016 to 2019
$1.5M
NCI NIH HHS R01 CA169158NHLBI NIH HHS R01 HL131405
6 · The paper itself

Abstract

Although the role of dopamine (DA) in malignant tumors has been reported, its function in premalignant lesions is unknown. Herein we report that the stimulation of DA D

Indexed as

AnimalsCells, CulturedDisease Models, AnimalDisease ProgressionDopamineDopamine AgonistsDopamine AntagonistsEndothelial CellsHumansKeratosis, ActinicMaleMicePrimary Cell CultureReceptors, Dopamine D2SkinUltraviolet RaysDopamineDopamine AgonistsDopamine AntagonistsDRD2 protein, humanDRD2 protein, mouseReceptors, Dopamine D2

Identifiers

PMID33846213
PMCPMC8295184
OpenAlexW3154275287

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.